Manchester Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.3K | Hold |
1,248
| – | – | 0.01% | 568 |
|
|
2025
Q1 | $37.7K | Buy |
1,248
+243
| +24% | +$7.33K | ﹤0.01% | 600 |
|
|
2024
Q4 | $35.1K | Buy |
1,005
+160
| +19% | +$5.59K | ﹤0.01% | 611 |
|
|
2024
Q3 | $33.9K | Buy |
845
+150
| +22% | +$6.01K | ﹤0.01% | 611 |
|
|
2024
Q2 | $33.1K | Buy |
695
+690
| +13,800% | +$32.9K | ﹤0.01% | 576 |
|
|
2024
Q1 | $217 | Hold |
5
| – | – | ﹤0.01% | 994 |
|
|
2023
Q4 | $253 | Hold |
5
| – | – | ﹤0.01% | 959 |
|
|
2023
Q3 | $227 | Buy |
+5
| New | +$227 | ﹤0.01% | 951 |
|
|
2021
Q1 | – | Sell |
-114
| Closed | -$6K | – | 709 |
|
|
2020
Q4 | $6K | Buy |
114
+8
| +8% | +$421 | ﹤0.01% | 517 |
|
|
2020
Q3 | $5K | Buy |
106
+5
| +5% | +$236 | ﹤0.01% | 448 |
|
|
2020
Q2 | $6K | Hold |
101
| – | – | ﹤0.01% | 496 |
|
|
2020
Q1 | $5K | Hold |
101
| – | – | ﹤0.01% | 487 |
|
|
2019
Q4 | $6K | Hold |
101
| – | – | ﹤0.01% | 483 |
|
|
2019
Q3 | $6K | Hold |
101
| – | – | ﹤0.01% | 478 |
|
|
2019
Q2 | $6K | Hold |
101
| – | – | ﹤0.01% | 513 |
|
|
2019
Q1 | $8K | Buy |
+101
| New | +$8K | ﹤0.01% | 574 |
|
|
2015
Q1 | – | Sell |
-4,304
| Closed | -$266K | – | 705 |
|
|
2014
Q4 | $266K | Hold |
4,304
| – | – | 0.03% | 291 |
|
|
2014
Q3 | $167K | Buy |
+4,304
| New | +$167K | 0.02% | 400 |
|
|
2014
Q2 | – | Sell |
-3,639
| Closed | -$157K | – | 1093 |
|
|
2014
Q1 | $157K | Sell |
3,639
-209
| -5% | -$9.02K | 0.03% | 402 |
|
|
2013
Q4 | $153K | Hold |
3,848
| – | – | 0.02% | 391 |
|
|
2013
Q3 | $144K | Buy |
+3,848
| New | +$144K | 0.02% | 398 |
|